Strix
26.1K

CVE-2023-26546

HIGHCVSS 8.8/10EPSS 1.44%

Last modified

CVE-2023-26546 is a high-severity vulnerability rated 8.8/10 on the CVSS scale. European Chemicals Agency IUCLID before 6.27.6 allows remote authenticated users to execute arbitrary code via Server Side Template Injection (SSTI) with a crafted template file. The attacker must have template manager permission.. EPSS estimates a 1.44% chance of exploitation in the next 30 days.

Description

European Chemicals Agency IUCLID before 6.27.6 allows remote authenticated users to execute arbitrary code via Server Side Template Injection (SSTI) with a crafted template file. The attacker must have template manager permission.

Metrics

CVSS 3.1
8.8/10

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

EPSS Probability
1.44%

69.8th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

VendorProductVersions
Echa.EuropaIuclid>= 5.15.0, < 6.27.6

References

Timeline

Published
Last Modified
Status
Modified

Frequently Asked Questions

What is CVE-2023-26546?
European Chemicals Agency IUCLID before 6.27.6 allows remote authenticated users to execute arbitrary code via Server Side Template Injection (SSTI) with a crafted template file. The attacker must have template manager permission.
How severe is CVE-2023-26546?
CVE-2023-26546 has a CVSS score of 8.8/10 (HIGH severity). The EPSS model estimates a 1.44% probability of exploitation in the next 30 days.
How do I fix CVE-2023-26546?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2023-26546?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST